Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Stana

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Breast Cancer (Tokyo, Japan)|December 5, 2021
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Cancers|February 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM ApproachesSara Vockner, Matthias Mattke, Ivan M Messner, et al.
Medical Sciences (Basel, Switzerland)|December 24, 2025
Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)Franz Zehentmayr, Josef Karner, Markus Stana, et al.
Journal of Clinical Medicine|December 30, 2025
MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)Alexandra Hochreiter, Markus Stana, Marisa Klebermass, et al.
Radiation Oncology (London, England)|November 11, 2023
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedureFalk Roeder, Gerd Fastner, Christoph Fussl, et al.
Journal of Clinical Medicine|February 13, 2025
Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)Elvis Ruznic, Marisa Klebermass, Barbara Zellinger, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Breast Cancer (Tokyo, Japan)|December 5, 2021
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Cancers|February 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM ApproachesSara Vockner, Matthias Mattke, Ivan M Messner, et al.
Medical Sciences (Basel, Switzerland)|December 24, 2025
Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)Franz Zehentmayr, Josef Karner, Markus Stana, et al.
Journal of Clinical Medicine|December 30, 2025
MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)Alexandra Hochreiter, Markus Stana, Marisa Klebermass, et al.
Radiation Oncology (London, England)|November 11, 2023
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedureFalk Roeder, Gerd Fastner, Christoph Fussl, et al.
Journal of Clinical Medicine|February 13, 2025
Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)Elvis Ruznic, Marisa Klebermass, Barbara Zellinger, et al.
Pageof 2